Enhanced albumin uptake by rat tumors

International Journal of Oncology

Volumn 11, Issue 3, 1997, Pages 497-507

  Wunder, A ^a,b   Stehle, G ^a,b   Sinn, H ^b   Schrenk, H H ^b   Hoff Biederbeck, D ^a   Bader, F ^b   Friedrich, E A ^b   Peschke, P ^b   Maier Borst, W ^b   Heene, D L ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Albumins metabolism; Albumins physiology; Albuminspharmacology; Cancer physiopathology; Indium 111; Iodine 131; Ovarian 342 tumor; Residualizing label; Scintigraphy; Walker 256 carcinosarcoma

Indexed keywords

PENTETATE INDIUM IN 111; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; SERUM ALBUMIN; TYRAMINE DEOXYSORBITOL I 131; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; RADIOISOTOPE DISTRIBUTION; RAT; SCINTIGRAPHY; TISSUE DISTRIBUTION; WALKER CARCINOMA;

EID: 12644255693     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.3.497     Document Type: Article

References (20)

1. Mider GB, Tesluk H and Morton JJ: Effects of Walker carcinoma 256 on food intake, body weight and nitrogen metabolism of growing rats. Acta Union Internat Contra Cancrum 6: 409-420, 1948.
2. Geigy scientific tables: Composition of blood. Ciba Geigy, Basle, Switzerland, 1984.
3. Babson AL and Winnick T: Protein transfer in tumor-bearing rats. Cancer Res 14: 606-611, 1954.
4. Easty GC, Yarnell MM and Andrews RD: The uptake of proteins by normal and tumor cells in vitro. Br J Cancer 18: 354-357, 1964.
5. 131I-tagged protein by Ehrlich ascites tumor cells. Exp Cell Res 24: 457-465, 1961.
6. Ghose T, Nairn RC and Fothergill JE: Uptake of proteins by malignant cells. Nature 196: 1108-1109, 1962.
7. Mego JL and McQueen JD: The uptake of labeled proteins by particulate fractions of tumor and normal tissues after injection into mice. Cancer Res 25: 865-869, 1965.
8. Rossing N: Albumin metabolism in neoplastic diseases. Scand J Clin Lab Invest 22: 211-216, 1968.
9. Jewell WR, Krishnan EC and Schloerb PR: Apparent ingress of albumin in Walker 256 tumor and rat muscle. Cancer Res 35: 405-408, 1975.
10. Ehrenreich BA and Cohn ZA: The uptake and digestion of iodinated serum albumin by macrophages in vitro. J Exp Med 126: 941-949, 1967.
11. De Nardo GL, De Nardo SJ, Miyao NP, Mills SL, Peng JS, O'Grady LF, Epstein AL and Young WC: Non-dehalogenation mechanisms for excretion of radioiodine after administration of labeled antibodies. Int J Biol Markers 3: 1-9, 1988.
12. Pittman RC and Steinberg D: A new approach for the assesing cumulative lysosomal degradation of proteins and other macromolecules. Biochem Biophys Res Commun 81: 1254-1259, 1978.
13. 3H]raffinose, a novel radioactive label for determining organ sites of catabolism of proteins in the circulation. J Biol Chem 254: 3547-3553, 1979.
14. Pittman RC, Carew TE, Glass CK, Green SR, Taylor CAJ and Attie AD: A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J 212: 791-800, 1983.
15. Thorpe SR, Baynes JW and Chroneos ZC: The design and application of residualizing labels for the studies of protein catabolism. FASEB J 7: 399-405, 1993.
16. Strobel JL, Cady SG, Borg TK, Terracio L, Baynes JW and Thorpe SR: Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues. J Biol Chem 261: 7989-7994, 1986.
17. Sinn H, Schrenk HH, Friedrich EA, Schilling U and Maier-Borst W: Design of compounds having an enhanced tumour uptake, using serum albumin as a carrier. Part I. Int J Rad Appl Instrum B 17: 819-827, 1990.
18. Schilling U, Friedrich EA, Sinn H, Schrenk HH, Clorius JH and Maier-Borst W: Design of compounds having enhanced tumour uptake, using serum albumin as a carrier. Part II. In vivo studies. Int J Rad Appl Instrum B 19: 685-695, 1992.
19. Sinn H, Schrenk HH, Friedrich EA, Via DP and Dresel HA: Radioiodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agent. Anal Biochem 170: 186-192, 1988.
20. Zeller WJ, Frühauf S, Chen G, Keppler BK, Frei E and Kaufmann M: Chemoresistance in rat ovarian tumours. Eur J Cancer 27: 62-67, 1991.